• Wed news: Wegovy sales soar. Trump wins - effect on healthcare remains unclear. Teva Pharma earnings. Lexicon Pharma’s persistence. Moderna’s Bancel steps down as sales chief. See more on our front page

Sotyktu floundering

Karen, the sales force was not doubled- you added a handful of reps to cover the new huge territories that nobody signed up for. It is a last ditch effort to turn this dog into a unicorn,but the numbers do not lie,BMS is bleeding large amounts of $$$ with Slowtyktu. It also makes it easier to lay us off. The layoff plan has already been finalized-new geographies actually make it easier- whack 50% of the sales force(mirrors) and you have the minimal amount of reps to beg for scripts for the 10th in line PSO product-- wake the f up, love your only cool DM
Listen Richard, the sales force increased by more than a "handful". But you would know that if you weren't well...a Richard. Keep trolling. It's the only really successful thing you got going.....then again...maybe not....there's always that "success side hustle" you have out of your mommas basement.
 




Listen Richard, the sales force increased by more than a "handful". But you would know that if you weren't well...a Richard. Keep trolling. It's the only really successful thing you got going.....then again...maybe not....there's always that "success side hustle" you have out of your mommas basement.
retention rate at 40% let's gooooooooooooo!!!
 




Sell the molecule, disband the dermatology division and reallocate assets in areas that will generate profits. This is the only way forward with Sotyktu. If you haven't left yet, you will be escorted out soon. There is no other viable option.